维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Cheymol"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effects of obesity on pharmacokinetics implications for drug therapy显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
2	Cyclosporine in whole blood drug monitoring difficulities and presentation of a reliable normal phase liquid chromatographic assay显示文摘	Poirier JM Lebot JM Cheymol G	1994	Ther Drug Monit1994，16，4：	1
3	Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects显示文摘	G. Cheymol R. Woestenborghs E. Snoeck R. Ianucci J.-P. Le Moing L. Naditch J. C. Levron J. M. Poirier	1997	European Journal of Clinical Pharmacology1997，，6：	1
4	Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers显示文摘	C. Jeunne J. M. Poirier G. Cheymol O. Ertzbischoff F. Engel F. C. Hugues	1991	European Journal of Clinical Pharmacology1991，，2：	1
5	Effects of obesity on pharmacokinetics implications for drug therapy显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
6	Effects of obesity on pharmacokinetics implications for drug therapy显示文摘	Cheymol C	2000	Clin Pharmacokinet2000，39，3：	1
7	Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects 显示文摘	Cheymol G Woestenborghs R Snoeck E	1997	Eur J Clin Pharmacol1997，5，6：	1
8	Effects of obesity on pharmacokinetics implica- tion for drug therapy 显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
9	Effects of obesity on pharmacokinetics implications for drug therapy显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
10	Cyclosporine in whole blood: Drug monitoring difficulities and presentation of an normal phase liquid chromatographic assay 显示文摘	POIRIER J M LEBOT J M CHEYMOL G	1994	Ther Drug Monit1994，16，：	1
11	Effects of obesity on pharmacokineties implieations for drug therapy 显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
12	Effects of obesity on pharma wkinetics implications for drug the rapy显示文摘	Cheymol G	2000	Clin Pharma cokinet2000，39，：	1
13	Clinical pharmacokinetics of drugs in obesity显示文摘	Cheymol G	1993	Chin Phamacokinet1993，25，2：	1
14	Recent aspect of monitoring the dosage of a minoglycosides and vancomycin显示文摘	Cheymol G Poirier JM	1998	Bull Acad Natl Med1998，182，2：	1
15	Effects of obesity on pharmacokinetics implications for drug therapy显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
16	Effects of obesity on pharmacokinetics implications for drug therapy 显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
17	Effects of obesity on pharmacokinetics:implications for drug therapy显示文摘	CHEYMOL G	2000	Clin Pharmacokinet2000，39，3：	1
18	Effects of obesity on pharmacokinetics implications for drug therapy显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
19	Optimisation of itraconazole therapy using target drug concentrations显示文摘	Poirier J M Cheymol G	1998	Clin Pharmacokinet1998，35，：	1
20	Effects of obesity on pharmacokinetics im- plications for drug therapy 显示文摘	CHEYMOL G	2000	Clin Pharmacokinet2000，39，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示